Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to Cisplatin-Based Doublet Chemotherapy Regimens among a Cohort of Medicare Patients Aged 70 and Older with Stage IV Non-Small Cell Lung Cancer.
Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to Cisplatin-Based Doublet Chemotherapy Regimens among a Cohort of Medicare Patients Aged 70 and Older with Stage IV Non-Small Cell Lung Cancer.
(xsd:string)
Superiority of Carboplatin-Based Doublet Chemotherapy Regimens to Cisplatin-Based Doublet Chemotherapy Regimens among a Cohort of Medicare Patients Aged 70 and Older with Stage IV Non-Small Cell Lung Cancer.
(xsd:string)